This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Why Healthcare Stocks Will Continue to Lead Market Higher

6/02/15 3:40 PM EDT
Healthcare stocks have traditionally been viewed as defensive, but over the past 5 years the sector has been the best performer the S&P 500. Mario Minotti, partner at Minotti Group Wealth Advisors, says the run in healthcare names is far from over. 'The healthcare sector is really dynamic right now and there has been huge investment in the arena spurred by the Affordable Care Act,' says Minotti. 'The growth has been across the board because it’s a broad industry that encompasses hospitals, pharmaceuticals, insurance companies and medical device players.' The Healthcare Select Sector SPDR, which owns shares of Johnson & Johnson and Pfizer, has returned 163% in the past 5 years, compared to a 140% gain for the second-place Consumer Discretionary SPDR and a 104% rise for the third-place Technology SPDR. When it comes to healthcare’s often volatile cousin biotech, Minotti says he is not turning away from it despite its high valuation. The iShares Nasdaq Biotechnology ETF, which holds stocks like Amgen and Gilead, is up 348% in the past 5 years. Its holdings also trade for an above market multiple of 25 times trailing 12 months earnings. 'Biotech is a high profile player in the healthcare sector and we are seeing more M&A than ever in that space,' says Minotti. 'It’s worth keeping an eye on because valuations are high but we still see a lot of growth potential there.
Stocks in this video: XLVXLEIBB
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs